Nancy Dubler

After The Screening

05/14/2008
Editorial Intern
After learning about the benefits of genetic screening from her physician, a pregnant woman decides to schedule an amniocentesis test. Doctors carefully screen her amniotic fluid sample, and they determine that her fetus has an extra 21st chromosome — in other words, the child will be born with Down syndrome. The patient instantly faces an emotional quandary: should she go forward with the pregnancy, or should she have an abortion? This kind of thorny ethical question was at the center of a forum on genetic disease forum held May 5 at the JCC in Manhattan.
Syndicate content